Bone Biologics Corp SEC filings BBLG
Bone Biologics Corp has 485 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 26, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jul 24, 2026 | — |
| S-3 | Shelf registration | Jul 17, 2026 | — |
| 424B5 | Prospectus supplement | Mar 13, 2026 | — |
| S-8 | Employee stock plan registration | Sep 26, 2025 | — |
| S-3/A | Filing | Aug 29, 2025 | — |
| 424B4 | Prospectus | Jun 30, 2025 | — |
| S-3 | Shelf registration | Jun 24, 2025 | — |
| S-1 | Registration statement | Jun 24, 2025 | — |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| S-3 | Shelf registration | Aug 12, 2024 | — |
| 424B4 | Prospectus | Mar 4, 2024 | — |
| S-1/A | Amended registration statement | Feb 26, 2024 | — |
| S-1/A | Amended registration statement | Feb 23, 2024 | — |
| S-1 | Registration statement | Jan 30, 2024 | — |
| S-3/A | Filing | Jan 17, 2024 | — |
| S-3 | Shelf registration | Jan 5, 2024 | — |
| 424B5 | Prospectus supplement | Nov 20, 2023 | — |
| S-8 | Employee stock plan registration | Sep 15, 2023 | — |
| 424B4 | Prospectus | Jun 16, 2023 | — |
| S-1/A | Amended registration statement | Jun 13, 2023 | — |
| S-1/A | Amended registration statement | Jun 6, 2023 | — |
| S-1 | Registration statement | May 1, 2023 | — |
| 424B4 | Prospectus | Oct 11, 2022 | — |
| S-1MEF | Filing | Oct 7, 2022 | — |
| S-1MEF | Filing | Oct 7, 2022 | — |
| S-1/A | Amended registration statement | Oct 5, 2022 | — |
| S-1/A | Amended registration statement | Oct 4, 2022 | — |
| S-1 | Registration statement | Sep 23, 2022 | — |
| S-3 | Shelf registration | Jun 28, 2022 | — |
| 424B5 | Prospectus supplement | Nov 2, 2021 | — |
| 424B4 | Prospectus | Oct 15, 2021 | — |
| 424B4 | Prospectus | Oct 15, 2021 | — |
| S-1MEF | Filing | Oct 12, 2021 | — |
| S-1/A | Amended registration statement | Oct 7, 2021 | — |
| S-1/A | Amended registration statement | Oct 6, 2021 | — |
| S-1/A | Amended registration statement | Aug 30, 2021 | — |
| S-1 | Registration statement | Jun 28, 2021 | — |
| POS AM | Filing | Oct 20, 2017 | — |
| POS AM | Filing | Oct 20, 2017 | — |
| POS AM | Filing | Oct 13, 2017 | — |
| POS AM | Filing | Oct 13, 2017 | — |
| POS AM | Filing | Sep 8, 2017 | — |
| POS AM | Filing | Sep 8, 2017 | — |
| S-1 | Registration statement | Aug 4, 2016 | — |
| S-8 | Employee stock plan registration | Aug 4, 2016 | — |
| POS AM | Filing | Jul 19, 2016 | — |
| S-1/A | Amended registration statement | May 28, 2015 | — |
| S-1/A | Amended registration statement | Apr 30, 2015 | — |
| S-1 | Registration statement | Nov 12, 2014 | — |
Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- BBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1419554
- Former names
- Bone Biologics, Corp. (until Nov 2, 2015); AFH ACQUISITION X, INC. (until Sep 15, 2014)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.